Ongoing clinical and scientific advances have transformed the field of ADHD. Substantial knowledge has been gained on the neurobiology, heritability, environmental, persistence, comorbid conditions, psychotherapeutic and pharmacological treatment of ADHD in children, adolescents and adults. This CME-accredited scientific meeting will feature nationally renowned ADHD faculty who will educate participants on recent research findings relevant to evidenced-based clinical practice with a focus on improving the quality of care for all patients with ADHD & related disorders. The keynote session this year is titled, Athletics & ADHD. The presenter will be Dr. David Baron, a world renowned expert in ADHD, who has worked extensively with Olympic athletes. The Plenary sessions will include New Neuroimaging Findings in ADHD presented by Dr. Phillip Shaw of the National Institute of Mental Health and, The Descriptive Psychopathology of ADHD: Mind Wandering Excessively and Affective Instability in Adults with ADHD, presented by Dr. Philip Asherson of King's College London. "This promises to be an exciting opportunity for participants to hear about the latest scientific developments in our field, and to learn new ways to improve clinical assessment and treatment of patients with ADHD across the lifespan" says Anthony L. Rostain, M.D., M.A., President of APSARD.
The meeting is designed for psychiatrists, psychologists, family physicians, pediatricians, nurse practitioners, and other professionals working to improve the quality of care for child, adolescent and adult patients with ADHD.